Assort Health
PrivateLast Round
Series C
Jun 24, 2026
Est. Valuation
$1.2B
Total Funding Raised
$221.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Assort Health operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series C round in June 2026.
Assort Health is a healthcare technology company that develops a conversational AI platform to automate patient access and call center operations for healthcare organizations.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Workflow Automation, NLP & Conversational AI, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Assort Health Comparables
Compare Assort Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Notable | 86% | |
| Syllable | 85% | |
| Artera | 85% |
For institutional investors. Book with your work email.
Assort Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 24, 2026 | ||||
| Series B | Sep 30, 2025 | ||||
| Series A | Apr 16, 2025 | ||||
| Seed | Mar 14, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Assort Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series C |
| Four Acres Capital | Series A, Seed |
| Chemistry VC | Series B, Series C, Series A |
| First Round Capital | Series B, Series C, Series A |
| Tau Ventures | Series A, Seed, Series C |
| Menlo Ventures | Series C |
| Quiet Capital | Series A, Series B, Series C, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 5, 2026
New digital intake and patient payment features added to Patient Journey Platform.
- Sep 25, 2026
Grew 38% QoQ, from 184 to 253 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 5, 2026
Assort Health announces digital intake and patient payment capabilities within its Patient Journey Platform, extending its AI agents to support previsit forms, patient information collection, and payments on Nov 5th '26.
- is_developingOct 9, 2026
Assort Health plans to codevelop a joint AI agent offering with Nextech for all Nextech customers, with deeper platform integration to automate patient access workflows in ophthalmology practices, in California on Oct 9th '26.
- has_valuationSep 25, 2026
Assort Health, a healthcare AI startup, reaches a $1.2B valuation in three years.
- integrates_withSep 17, 2026
Assort Health's direct integration with NextGen Healthcare, Inc. lets its AI agents complete patient scheduling actions inside the EHR, and First State Orthopaedics uses it in live workflows after a rapid deployment.
- launchesAug 12, 2026
On Aug 12th '26 in California, Assort Health unveils the generally available Referrals AI agent, which processes and triages inbound referrals, carries out Continuous Patient Conversations, and helps specialty practices and health systems recover patient volume and revenue lost in manual referral workflows.
For institutional investors. Book with your work email.
Assort Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Assort Health's valuation, stock price, and market status.
Is Assort Health a public or private company?
Assort Health is a private company.
What is the current stock price of Assort Health?
Assort Health is a private company, so its shares have no public market price. Caplight tracks Assort Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Assort Health worth (valuation)?
Assort Health's valuation is estimated at $1.2B based on funding round data.
Can I buy Assort Health stock?
Assort Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Assort Health's last funding round?
Assort Health's most recent funding round was Series C on June 24, 2026.
Who are the main investors in Assort Health?
Key investors in Assort Health include Chemistry VC, First Round Capital, Menlo Ventures, Quiet Capital, Lightspeed Venture Partners.
Will Assort Health IPO soon?
No public IPO plans have been announced for Assort Health.
How can I track Assort Health secondary market activity?
Caplight tracks bids, offers, and trades in Assort Health's shares on secondary markets.